Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223275 · ClinicalTrials.gov registry record · Phase 4
Naltrexone for Bipolar Disorder and Alcohol Dependence
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00223275 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT00223275, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The abuse of alcohol is especially common in people with bipolar disorder. However, very little is known about how to treat people with both bipolar disorder and alcohol abuse/dependence. The purpose of this research is to determine whether naltrexone add-on therapy is associated with a greater reduction in alcohol use and alcohol craving than with placebo (an inactive substance) therapy.
Interventions
- DRUG Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00223275
The ClinicalTrials.gov registry entry for NCT00223275 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naltrexone is the first listed.
NCT00223275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00223275 about?
NCT00223275 is a clinical study titled "Naltrexone for Bipolar Disorder and Alcohol Dependence". The abuse of alcohol is especially common in people with bipolar disorder. However, very little is known about how to treat people with both bipolar disorder and alcohol abuse/dependence. The purpose of this research is to determine whether naltrexone add-on therapy is associated with a greater redu...
What is the current status of trial NCT00223275?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2005-05. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00223275?
The interventions under investigation include: Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00223275?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.